Detection of Exogenous Growth Hormone (GH) Administration by Monitoring Ratio of 20kDa- and 22kDa-GH in Serum and Urine

We previously demonstrated that individual subjects have fairly constant ratios of serum concentrations of 20kDa- (20K) and 22kDa-GH (22K). The aim of this study is to demonstrate the possibility of utilizing the changes in the ratio of 20K/22K for detecting the exogenous administration of 22K. A ma...

Full description

Saved in:
Bibliographic Details
Published in:ENDOCRINE JOURNAL 2000, Vol.47(1), pp.97-101
Main Authors: MOMOMURA, SHINICHI, HASHIMOTO, YOSHIHIDE, SHIMAZAKI, YUKIO, IRIE, MINORU
Format: Article
Language:English
Subjects:
20kDa-GH
22kDa-GH
Cardiomyopathy, Dilated - blood
Cardiomyopathy, Dilated - drug therapy
Cardiomyopathy, Dilated - urine
Doping
ELISA
Enzyme-Linked Immunosorbent Assay - standards
Growth Hormone - blood
Growth Hormone - chemistry
Growth Hormone - therapeutic use
Growth Hormone - urine
Humans
Male
Middle Aged
Molecular Weight
Osmolar Concentration
Time Factors
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We previously demonstrated that individual subjects have fairly constant ratios of serum concentrations of 20kDa- (20K) and 22kDa-GH (22K). The aim of this study is to demonstrate the possibility of utilizing the changes in the ratio of 20K/22K for detecting the exogenous administration of 22K. A male patient with idiopathic dilated cardiomyopathy (age 51) received 22K (4U, s.c.) every other day. The concentrations of 20K and 22K in serum and urine were measured using enzyme-linked immunosorbent assays before and after administration. The administration of 22K increased total GH concentration, and markedly decreased the ratio of 20K/22K in serum, especially 2-10h after the administration. From calculations, it became clear that the concentration of exogenous 22K reached a peak between 2-4h after the administration and decreased to a negligible level after 24h. The ratio of 20K/22K in the 0-24h urine was 5 times lower than that in the 24-48h urine. These data suggest that, by monitoring the ratio of 20K/22K in serum or urine, it is possible to determine whether or not GH has been externally administered and to calculate the serum GH that has been administered.
ISSN:0918-8959
1348-4540
DOI:10.1507/endocrj.47.97